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During an immune response antigen-primed B-cells increase their antigen responsiveness by aﬃnity maturation mediated by
somatic hypermutation of the genes encoding the antigen-speciﬁc B-cell receptor (BCR) and by selection of higher-aﬃnity B
cell clones. Unlike the BCR, the T-cell receptor (TCR) cannot undergo aﬃnity maturation. Nevertheless, antigen-primed T cells
signiﬁcantly increase their antigen responsiveness compared to antigen-inexperienced (na¨ ıve) T cells in a process called functional
aviditymaturation.ThispapercoversstudiesthatdescribediﬀerencesinT-cellantigenresponsivenessduringT-celldiﬀerentiation
along with examples of the mechanisms behind functional avidity maturation in T cells.
1.Introduction
T lymphocytes are very potent cells that play key roles in
our immune system; without T cells we would quickly die
from infection. The T cells patrol our organism to guard
us against pathogenic microorganisms as part of adaptive
immunity. In secondary lymphoid organs, such as lymph
nodes and the spleen, small peptide fragments (antigens) of
thepathogensarepresentedtoantigen-inexperienced(na¨ ıve)
T cells by professional antigen presenting cells (APC). This
encounter induces proliferation and diﬀerentiation of the
naive T-cell into an armed T-cell population that migrates
to the site of infection. Here, reencounter with the same
pathogen rapidly triggers the eﬀector function of the armed
T cells resulting in elimination of the pathogen. Following
antigen clearance, most of the eﬀector T cells die leaving
only a small population of memory T cells. In case of re-
infection with the same pathogen, memory T cells will
mountapromptresponsebyimmediatelyproducingeﬀector
cytokines and by rapidly proliferating into a large number
of secondary eﬀectors [1–4]. This substantial increase in
antigen-responsiveness of both eﬀector and memory T cells
upon reencounter with the pathogen is a fundamental prop-
erty of adaptive immunity.
2. The Concept of Functional
AvidityMaturation
Lymphocytes recognize antigens through specialized antigen
receptors. These include the B-cell receptor (BCR) on B cells
andtheT-cellreceptors(TCR)onTcells.Duringthecauseof
an immune response, a high number of point mutations take
place in the BCR genes of the dividing B cells. This result in a
panelofBcellsexpressingBCRwithvaryingaﬃnitiesagainst
the antigen, and the B cells carrying BCR with the highest
aﬃnity are selectively expanded. As a consequence, high-
eﬃciency B cells are selected during the immune response
in a process known as aﬃnity maturation [5]. Unlike B cells,
T cells lack the capacity to mutate their TCR genes after T-
cellactivation,andthusclassicalaﬃnitymaturationdoesnot
take place in T cells. Still, T-cell sensitivity to antigens can
be extensively enhanced in antigen-experienced (primed) T
cells compared to na¨ ıve T cells in a process called “functional
avidity maturation” [6–13].2 Clinical and Developmental Immunology
3.T-CellActivationSignals:TheBasisof
FunctionalAvidityMaturation
3.1. Early Studies That Indicated the Existence of Functional
Avidity Maturation. The observation that fundamental dif-
ferencesexistinantigensensitivitybetweenna¨ ıveandprimed
T cells was ﬁrst described in the late 80 sb yC o o p e ra n d
coworkers. They found that only primed T cells produced
IL-2 and proliferated in vitro in response to TCR triggering
inducedbyanti-CD3antibodiesandmonocytes[14].Similar
observations were later reported by others [7, 9–13, 15].
Cooper and co-workers also introduced the idea that signals
in addition to TCR signals, here exempliﬁed by IL-2 receptor
signals, were required for activation of na¨ ıve T cells [14].
Along this line, Mark Davis’ group demonstrated that in
addition to TCR signals na¨ ıve T cells require costimulatory
signals through CD28 to become fully activated [16]. This
ﬁnding was supported in a subsequent study, where Croft
et al. showed that activation of both eﬀector and memory
T cells were considerably less dependent on co-stimulatory
signals than na¨ ıve T cells [9]. Several in vivo and ex vivo
studies have conﬁrmed the early observations that eﬀector
and memory T cells have a lower threshold of activation
and respond more robustly than na¨ ıve T cells [12, 13, 17].
As an example, Slifka and Whitton demonstrated a 50
fold increase in T-cell responsiveness to antigen during a
LCMV infection. Furthermore, they found that coengage-
ment of the coreceptor CD8 with the TCR was required
for na¨ ıve T-cell activation, whereas activation of eﬀector T
cells was relatively CD8-independent [17]. In an equivalent
study also examining T-cell responses to infection, Pihlgren
et al. demonstrated a similar 50-fold increase in antigen
responsiveness of both eﬀector and memory cell populations
as compared to na¨ ıve cells [12]. Interestingly, a study by
Mescher and co-workers suggested that memory T cells
were intrinsically more sensitive to TCR stimulation than
their na¨ ıve counterparts [13], adding TCR signaling to the
growing list of diﬀerences between na¨ ıve and primed T cells.
An overview of studies indicating the existence of functional
avidity maturation is given in Table 1.
Today, it is widely accepted that T-cell activation should
not be considered as a single signal process, but as a
sum of interdependent signals. The current model for T-
cell activation, referred to as the 3-signal model, predicts
that in addition to antigen-induced TCR-triggering optimal
activation of na¨ ıve T cells requires at least two additional
signals. These signals are delivered through co-stimulatory
receptors predominantly CD28 [18, 19] and receptors for
cytokines like IL-2, IL-12, IFN-α, and IL-1 [20–25].
3.2. TCR Signal Initiation in Na¨ ıve versus Primed T Cells:
The Immunological Synapse and CD28. TCR signaling takes
place at the interface between the T-cell and the antigen
presenting cell. At this contact zone, often referred to as
the immunological synapse (IS), TCR-signaling components
including the TCR itself as well as intracellular-signaling
molecules are continuously accumulated during antigen
contact [26]. Although somewhat controversial [26, 27],
formation of an IS correlates with generation of a robust
immune response, and is considered a prerequisite for T-
cell activation [28, 29]. Even so, new insight into the
biology of immunological synapses has revealed that TCR
signaling is already initiated in TCR microclusters prior to
IS formation. In a ligand-dependent manner, CD28 localizes
to preformed TCR microclusters counting 11–17 TCRs [30]
together with key signaling molecules [31]. Formation of
the mature IS includes accumulation of hundreds of such
TCR microclusters [31]. At the IS, CD28 signaling both
induces structural stabilization and enlargement of the area
itself [32, 33]. Formation of the IS is a mechanism shared
by na¨ ıve and primed T cells; however, a mature IS is
formed more quickly in primed T cells and only na¨ ıve T
cells require CD28 co-stimulatory signals to form the IS
[34, 35]. These observations are consistent with reports
indicating that primed T cells are less dependent on CD28-
costimulation than na¨ ıve T cells [9, 36–38]. Eventhough
the exact implication of CD28 signaling in T-cell activation
is still elusive, it is generally agreed that CD28 ampliﬁes
intracellular signaling induced by antigen-triggering of the
TCR through modulation of morphological features and
TCR signals [32, 33]. In addition to CD28, signaling other
diﬀerences between na¨ ıve and primed T cells exists at
the IS. A study by Watson and Lee illustrated that the
phosphatase CD45 is a more integral component of the IS
in primed T cells as compared to na¨ ıve cells [35]. CD45 is
a transmembrane tyrosine phosphatase that maintains Lck
activity by promoting dephosphorylation of an inhibitory
carboxy-terminal tyrosine residue of Lck. Lck activity is
a necessity for initiation of TCR signal transduction [39].
Interestingly, Watson and Lee also showed that CD45 is
already associated with TCR microdomains in the plasma
membrane prior to synapse formation in resting memory
T cells in contrast to their na¨ ıve counterparts [35]. This
ﬁnding parallels the study of Kersh et al. who showed that a
higherbasallevelofphosphorylation(activation)wasseenin
membrane associated signaling molecules in resting primed
T cells [40]. It, therefore, appears that primed T cells are in a
higher “state of alert” prior to antigen encounter, correlating
with the higher sensitivity of primed T cells to antigen
stimulation.
3.3. TCR Signaling in Na¨ ı v ev e r s u sP r i m e dTC e l l s .In
addition to diﬀerences in the organization of signaling mol-
ecules, the actual TCR signaling events induced in na¨ ıve
and primed T cells following TCR triggering diﬀers. The
current model for TCR signaling postulates that following
TCR triggering the tyrosine kinase Lck is activated resulting
in phosphorylation of the CD3 and zeta chains of the
TCR in addition to activation of Zap70 [41, 42]. Activated
Zap70 phosphorylates LAT that subsequently recruits and
activates several proteins including PLC-γ1. Activation of
PLC-γ1 results in the hydrolysis of phosphatidylinositol 4,5-
biphosphate (PIP2) to inositol 3,4,5-triphosphate (IP3) and
diacylglycerol (DAG). IP3 regulates intracellular calcium
mobilization, and DAG regulates the activation of PKC and
contributes to Ras and mitogen-activated protein kinaseClinical and Developmental Immunology 3
Table 1: Studies describing diﬀerences in antigen sensitivity between na¨ ıve and primed T cells. Diﬀerences listed are in comparison to na¨ ıve
Tc e l l s .
Study Species T-cell
phenotype Eﬀector T cell Memory T-cell Mode of
(re)-stimulation
Slifka and Whitton
[17], 2001 Mouse CD8 >50 fold ↑ Ag
responsiveness
>50 fold ↑ Ag
responsiveness Peptide antigen
Pihlgren et al. [12],
1996 Mouse CD8
50 fold ↑ Ag
responsiveness
(proliferation)
50 fold ↑ Ag
responsiveness
(proliferation)
In vivo or
peptide-pulsed
splenocytes
Curtsinger et al.
[13], 1998 Mouse CD8
↑ Ag
responsiveness
(e.g., proliferation)
Beads coated with
MHC/peptide
Robinson et al.
[10], 1993 Human CD3
↑ Responsiveness
to TCR triggering
(e.g., proliferation)
Soluble anti-CD3 Ab
Sanders et al. [7],
1989 Human CD3
↑ Responsiveness
to TCR triggering
(e.g., proliferation)
Soluble anti-CD3 Ab
Schwinzer et al.
[11], 1994 Human CD3 ↑ Proliferation Anti-CD3 Ab + APC
Byrne et al. [14],
1988 Human CD4 ↑ Proliferation Anti-CD3 Ab + APC
Croft et al. [9],
1994 Mouse CD4 ↑ Proliferation ↑ Proliferation
Anti-CD3 Ab + APC
lacking
co-stimulation
Luqman and
Bottomly [8], 1992 Mouse CD4 ↑ Proliferation
Anti-CD3 Ab + APC
lacking
co-stimulation
(MAPK) cascade activation [41, 42]. The vast majority of
studies contributing to the current model for TCR signaling
were performed using immortal T-cell lines or primed T
cells propagated in vitro. However, as signiﬁcant diﬀerences
in gene and protein expression exist between na¨ ıve and
primed T cells [43], signiﬁcant diﬀerences in TCR signaling
in primed and na¨ ıve T cells could be imagined. By studying
na¨ ıve human T cells isolated from freshly drawn blood
samples, we have recently shown that the classical model
for TCR signaling must be revised as na¨ ı v eTc e l l so n l y
express PLC-γ1 at very low levels compared to primed
(eﬀector) T cells. Following in vitro priming, PLC-γ1w a s
upregulated approximately 75 fold, an upregulation that
correlated with greater TCR responsiveness [44]. One of
the striking signaling diﬀerences that we and others have
observed between na¨ ıve and primed T cells is a strongly
diminished ability of na¨ ıve T cells to ﬂux calcium in response
to TCR triggering [10, 44, 45]. The very low expression
of PLC-γ1i nn a ¨ ıve T cells could explain the impaired
calcium ﬂux in these cells [44] .B a s e do np r e v i o u ss t u d i e s
demonstrating that vitamin D can up-regulate PLC-γ1i n
other cell types [46, 47], we investigated if vitamin D via
the vitamin D receptor (VDR) was responsible for PLC-
γ1 up-regulation during T-cell priming. Indeed, we found
thatVDR was quickly up-regulated following TCR triggering
and that induction of VDR was required for PLC-γ1u p -
regulation. As PLC-γ1 is a central molecule in the classical
TCR signaling pathway and is weakly expressed in na¨ ıve
human T cells, we wondered which signaling events could be
responsible for the activation-induced VDR up-regulation.
We found that the nonclassical TCR signaling pathway in
which Zap70 directly activates p38-induced VDR expression.
We further found that whereas activation of Zap70 and p38
was at least as eﬃcient in na¨ ı v eTc e l l sa si np r i m e dTc e l l s
following TCR triggering, activation of Erk was signiﬁcantly
reduced in na¨ ıve T cells. Thus, our study demonstrated
that fundamental diﬀerences exist in the signaling pathways
between na¨ ıve and primed T cells.
Adachi and Davis also compared TCR signaling in
human na¨ ıve and primed (memory) T cells. In contrast to
us, they found a stronger Erk activation along with lower
activation of Zap70 and p38 in na¨ ıve T cells as compared to
primed cells. They proposed that the strong Erk activation
observed in na¨ ıve T cells disrupted early TCR signaling
events as part of a negative feedback mechanism [48]. The
discrepancy between the two human studies might be due
to two diﬀerent primed T-cell populations studied (eﬀector
and memory cells, resp.); however, it might also be explained
by the diﬀerent modes of TCR triggering used. In our study,
puriﬁed na¨ ıve human T cells were stimulated using beads
coatedwith anti-CD3 andanti-CD28 antibodies. Adachiand
Davis used high concentrations of soluble anti-CD3 and
anti-CD28 antibodies cross-linked by secondary antibodies
to stimulate the T cells. By using cross-linked antibodies for
stimulation, a very strong receptor signaling is achieved. As
illustrated in a series of mouse virus studies, the strength
of TCR signaling determines the requirement for additional
activation signals like CD28 signaling and also results in4 Clinical and Developmental Immunology
Table 2: Studies describing diﬀerences in the TCR signaling machinery of na¨ ıve and primed T cells. Green cells indicate the investigated T
cell populations. Arrows indicate an increase. P denotes phosphorylation of the given enzyme following TCR triggering.
T cell
phenotype
Mode of
(re)-stimulation
Study Species
von Essen et al.
[44], 2010
Robinson et al.
[10], 1993
Kersh et al. [40],
2003
Watson and Lee
[35], 2004
Human
Human
Human
Mouse
Mouse
Mouse
CD3
CD3
CD4 + CD8
CD4
CD4
CD8
↑ Zap70-P,
LAT-P, p38-P
↑
ﬂux (CD4
cells only)
PLCγ1-P
absent
Na¨ ıve T cell
↑ PLCγ1/VDR,
Memory T cell
Peptide-pulsed
splenocytes
Peptide-pulsed
splenocytes or
macrofages
Peptide-pulsed
ﬁbroblasts
secondary Ab
Beads coated with
anti-CD3 + anti-CD28 Ab
Soluble anti-CD3 Ab
Eﬀector T cell
↑ Zap70-P
↑ Basal phosphoprotein
level in membrane
microdomains
↑ Microdomain size
Ericsson et al.
[45],1996
Adachi and
Davisa [48], 2011
↑
↑ Basal level of DAG
↑ Erk-P, p38-P, LAT-P
↑ Basal phosphoprotein
level in membrane
microdomains
↑ Microdomain size
↑ CD45 association with
microdomains + IS
↑ Formation and
maintenance of IS
PLCγ
↑ MAPK-P, RasGAP-P
↑
(CD4 + CD8)
cross-linked with a
Erk-P, Ca2+
Ca2+ ﬂux, PKC activity
p38-P, LAT-P, Ca2+ ﬂux Anti-CD3 + anti-CD28 Ab
1-P, Ca2+ ﬂux
Erk-P, Ca2+ ﬂux
somewhat diﬀerent responses [19]. In line with this, Adachi
and Davis found that na¨ ıve CD4 T cells could ﬂux calcium
when their stimulation protocol was used, implying very
strong signaling and the need for a fast negative feedback
mechanism. Both scenarios could be relevant for human
immunity where a wide range of pathogens with diﬀerent
origins is encountered.
A few studies investigating TCR signaling events in na¨ ıve
versus primed T cells have also been conducted in mice
[40]. Unfortunately, mouse and man seem to diﬀer when it
comes to some of the signaling molecules involved in TCR
signaling. In contrast to human T cells, na¨ ıve and primed
mouse T cells seem to express similar levels of both VDR
and PLC-γ1[ 45, 49]. Even so, studies on mice T cells have
found that it is only in primed T cells that TCR triggering
induces phosphorylation of PLC-γ1 and subsequent calcium
ﬂux [45] as found for human T cells. It is, therefore, likely
that despite a diﬀerent “route of action” the outcome are the
same concerning the ability to ﬂux calcium in T cells from
man and mice.
Collectively, these studies illustrate fundamental diﬀer-
ences in TCR signaling pathways between na¨ ıve and primed
T cells, diﬀerences based in particular on the lack of na¨ ıve
T-cell signaling molecules used by the primed T cells. A
detailedoverviewofthepublisheddiﬀerencesinthesignaling
machinery in na¨ ıve versus eﬀector and memory T cells is
given in Table 2.
3.4. Cytokines as the “Third” Activation Signal in Na¨ ıve versus
Primed T Cells. Within the last years, the importance of
cytokinereceptorsignalingasa“third-signal”inactivationof
na¨ ıve T cells has been acknowledged. The requirement for a
“signal 3” mediated by inﬂammatory cytokines is considered
a mean for T cells to determine if “danger” is present [50].
Although both na¨ ıve CD4 and CD8 T cells are dependent on
these “danger signals” for full activation, they diﬀer in their
requirement for speciﬁc cytokines. Early studies describing
a need for a third-signal cytokine came from a series of
in vitro and in vivo experiments performed by Mesher and
co-workers. They found that IL-12 and IFN-α provided a
signalthatalongwithantigenandCD28signalingwascrucial
for na¨ ıve CD8 T-cell expansion and diﬀerentiation [51–
53], ﬁndings that were validated by other groups [23, 54–
57]. Eventhough IL-12 has a role in skewing the CD4 T-
cell response, it has no eﬀect on CD4 T-cell proliferation
and diﬀerentiation in response to antigen. In contrast, IL-
1e n h a n c e sin vivo expansion and diﬀerentiation of na¨ ıve
CD4 T cells [58], both by acting directly on the CD4 T
cells [24] and through APC modiﬁcations [25]. No studies
have described a need for “the third-signal” in activation
of primed T cells, but a role for IFN-α in homeostatic
proliferation and maintenance of memory CD8 T cells has
beendemonstrated[59].Thus,eventhoughprimedTcellsto
some extent rely on both IFN-α [59] and CD28 [19] for their
continuous survival and antigen recognition, primed T cells
clearly do not have the same prerequisite for cytokine and
CD28 signaling as na¨ ıve T cells to be activated. The present
literature, therefore, clearly states that the demand for the “3
signals” in T-cell activation greatly diﬀers between na¨ ıve and
primed T cells.Clinical and Developmental Immunology 5
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Figure 1: Simpliﬁed model illustrating the diﬀerences in T-cell signaling between na¨ ıve and primed T cells. In na¨ ıve human T cells, TCR
engagement leads to activation of p38 through Zap70 resulting in upregulation of VDR and then PLC-γ1 mandatory for the na¨ ıve T cells
to be activated. For activation, na¨ ıve T cells also require CD28 and cytokine receptor signals to induce and stabilize membrane structures
and intracellular signaling molecules. In contrast, primed T cells already express PLC-γ1, have a higher DAG and phosphoprotein (P) basal
level in specialized membrane structures with a high association of the CD45 molecule. In addition, signaling in primed T cells is rather
independent of CD28 costimulatory signals as well as “third-signal” inﬂammatory cytokines, overall leading to a far more prompt antigenic
response.
4.MolecularMechanismsof Functional
AvidityMaturation
As discussed in this paper and summarized in Figure 1,
fundamental diﬀerences in activation of na¨ ıve and primed
T cells exist. This includes both the requirement for the
threeantigenic-inducedsignalsaswellasintrinsicdiﬀerences
in the signaling machinery. CD28 and cytokine receptor
signaling are central components of na¨ ıve T-cell activa-
tion as they help induce and stabilize both membrane
structures and intracellular signaling molecules crucial for
T-cell activation. In this way, the signaling machinery is
already optimized for signal transduction in primed T
cells prior to antigen reencounter. As a result, primed T
cells respond much faster and stronger when an antigen is
eventually engaged. It therefore seems as the T cells retain
a permanent imprint of a prior response to antigen. But
how is such an imprint formed? Accumulating evidence
suggest that epigenetic changes are likely to be a contributing
factor. For example, Northrop et al. demonstrated that stable
demethylation of the regulatory region of the IL-2 gene takes
placeduring priming of na¨ ıveT cellsresulting in againofIL-
2 expression in the primed T cells [60], a discovery validated
by Murayama and co-workers [61]. In addition, Thomas
et al. published the observation that CD28 costimulation
during T-cell priming induces a stable histone acetylation
and demethylation at the IL-2 promoter, suggesting that
CD28 in part function through epigenetic mechanisms [62].
A personal observation of ours shows that CD28 signaling
greatly increases the TCR induced upregulation of VDR in
na¨ ıve T cells. In parallel with this, Kim et al. recently pub-
lished that transcription of the gene CYP27B1 is controlled
by methylation of its promoter [63]. The CYP27B1 gene
product controls synthesis of active vitamin D, which is a
prerequisite for VDR activity and hence for upregulation of
PLC-γ1i nn a ¨ ıve T cells. Moreover, it has been speculated
that the “third-signal” cytokines IL-12 and IFN-α drive
chromatin remodeling events during initial priming of na¨ ıve6 Clinical and Developmental Immunology
T cells [50]. It therefore seems likely that the more rapid
and robust responses of primed T cells in comparison to
na¨ ıve cells partly are a result from epigenetic changes in
crucial genes, and furthermore that these changes may be
driven by CD28 costimulation and “third-signal” cytokines
during the initial priming phase. Despite the progress made
in recent years, we still lack a clear understanding of some
of the key aspects of functional avidity maturation. A better
understanding of the molecular mechanisms involved in
improving antigen-speciﬁc T-cell responses would be of
great therapeutic value, for example, to advance vaccine
eﬃciency.
References
[1] S. M. Kaech, E. J. Wherry, and R. Ahmed, “Eﬀector and
memory T-cell diﬀerentiation: implications for vaccine devel-
opment,” Nature Reviews Immunology, vol. 2, no. 4, pp. 251–
262, 2002.
[2] D. Masopust and R. Ahmed, “Reﬂections on CD8 T-cell acti-
vation and memory,” Immunologic Research, vol. 29, no. 1–3,
pp. 151–160, 2004.
[ 3 ]T .S .G o u r l e y ,E .J .W h e r r y ,D .M a s o p u s t ,a n dR .A h m e d ,
“Generation and maintenance of immunological memory,”
Seminars in Immunology, vol. 16, no. 5, pp. 323–333, 2004.
[ 4 ]B .R o c h aa n dC .T a n c h o t ,“ C D 8Tc e l lm e m o r y , ”Seminars in
Immunology, vol. 16, no. 5, pp. 305–314, 2004.
[ 5 ]J .U .P e l e d ,L .K .F e i ,M .D .I g l e s i a s - U s s e le ta l . ,“ T h eb i -
ochemistry of somatic hypermutation,” Annual Review of
Immunology, vol. 26, pp. 481–511, 2008.
[6] M. K. Slifka and J. L. Whitton, “Functional avidity maturation
of CD8+ T cells without selection of higher aﬃnity TCR,”
Nature Immunology, vol. 2, no. 8, pp. 711–717, 2001.
[ 7 ]M .E .S a n d e r s ,M .W .M a k g o b a ,C .H .J u n e ,H .A .Y o u n g ,
and S. Shaw, “Enhanced responsiveness of human memory T
cellstoCD2andCD3receptor-mediatedactivation,”European
Journal of Immunology, vol. 19, no. 5, pp. 803–808, 1989.
[8] M. Luqman and K. Bottomly, “Activation requirements for
CD4+ Tc e l l sd i ﬀering in CD45R expression,” Journal of
Immunology, vol. 149, no. 7, pp. 2300–2306, 1992.
[9] M. Croft, L. M. Bradley, and S. L. Swain, “Naive versus
memory CD4 T cell response to antigen: memory cells are less
dependent on accessory cell costimulation and can respond to
many antigen- presenting cell types including resting B cells,”
Journal of Immunology, vol. 152, no. 6, pp. 2675–2685, 1994.
[10] A. T. Robinson, N. Miller, and D. R. Alexander, “CD3 antigen-
mediated calcium signals and protein kinase C activation are
higher in CD45RO+ than in CD45RA+ human T lymphocyte
subsets,” European Journal of Immunology, vol. 23, no. 1, pp.
61–68, 1993.
[11] R. Schwinzer, R. Siefken, R. A. Franklin, J. Saloga, K. Wonigeit,
and E. W. Gelfand, “Human CD45RA+ and CD45R0+ Tc e l l s
exhibit similar CD3/T cell receptor-mediated transmembrane
signaling capacities but diﬀer in response to co-stimulatory
signals,” European Journal of Immunology, vol. 24, no. 6, pp.
1391–1395, 1994.
[12] M. Pihlgren, P. M. Dubois, M. Tomkowiak, T. Sj¨ ogren, and J.
Marvel, “Resting memory CD8+ T cells are hyperreactive to
antigenic challenge in vitro,” Journal of Experimental Medicine,
vol. 184, no. 6, pp. 2141–2151, 1996.
[13] J. M. Curtsinger, D. C. Lins, and M. F. Mescher, “CD8+
memory T cells (CD44(high), Ly-6C+) are more sensitive than
naive cells (CD44(low), Ly-6C-) to TCR/CD8 signaling in
response to antigen,” Journal of Immunology, vol. 160, no. 7,
pp. 3236–3243, 1998.
[14] J. A. Byrne, J. L. Butler, and M. D. Cooper, “Diﬀerential acti-
vation requirements for virgin and memory T cells,” Journal of
Immunology, vol. 141, no. 10, pp. 3249–3257, 1988.
[15] D. Leitenberg, F. Balamuth, and K. Bottomly, “Changes in
the T cell receptor macromolecular signaling complex and
membrane microdomains during T cell development and
activation,” Seminars in Immunology, vol. 13, no. 2, pp. 129–
138, 2001.
[ 1 6 ]C .G .S a g e r s t r o m ,E .M .K e r r ,J .P .A l l i s o n ,a n dM .M .D a v i s ,
“Activation and diﬀerentiation requirements of primary T
cells in vitro,” Proceedings of the National Academy of Sciences
of the United States of America, vol. 90, no. 19, pp. 8987–8991,
1993.
[17] M. K. Slifka and J. L. Whitton, “Functional avidity maturation
of CD8+ T cells without selection of higher aﬃnity TCR,”
Nature Immunology, vol. 2, no. 8, pp. 711–717, 2001.
[18] J.A.Bluestone,“NewperspectivesofCD28-B7mediatedTcell
costimulation,” Immunity, vol. 2, no. 6, pp. 555–559, 1995.
[19] A. C. Boesteanu and P. D. Katsikis, “Memory T cells need
CD28 costimulation to remember,” Seminars in Immunology,
vol. 21, no. 2, pp. 69–77, 2009.
[20] S. Letourneau, C. Krieg, G. Pantaleo, and O. Boyman, “IL-2-
and CD25-dependent immunoregulatory mechanisms in the
homeostasis of T-cell subsets,” Journal of Allergy and Clinical
Immunology, vol. 123, no. 4, pp. 758–762, 2009.
[21] J. M. Curtsinger, C. S. Schmidt, A. Mondino et al., “Inﬂam-
matory cytokines provide a third signal for activation of naive
CD4+ and CD8+ Tc e l l s , ”Journal of Immunology, vol. 162, no.
6, pp. 3256–3262, 1999.
[ 2 2 ] A .A .F i l a t e n k o v ,E .L .J a c o v e t ty ,U .B .F i s c h e r ,J .M .C u rt s i n g e r ,
M. F. Mescher, and E. Ingulli, “CD4 T cell-dependent con-
ditioning of dendritic cells to produce IL-12 results in CD8-
mediated graft rejection and avoidance of tolerance,” Journal
of Immunology, vol. 174, no. 11, pp. 6909–6917, 2005.
[23] G. A. Kolumam, S. Thomas, L. J. Thompson, J. Sprent, and K.
Murali-Krishna,“TypeIinterferonsactdirectlyonCD8Tcells
to allow clonal expansion and memory formation in response
to viral infection,” Journal of Experimental Medicine, vol. 202,
no. 5, pp. 637–650, 2005.
[24] S. Z. Ben-Sasson, J. Hu-Li, J. Quiel et al., “IL-1 acts directly
on CD4 T cells to enhance their antigen-driven expansion
and diﬀerentiation,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 106, no. 17, pp.
7119–7124, 2009.
[25] A. Khoruts, R. E. Osness, and M. K. Jenkins, “IL-1 acts on
antigen-presenting cells to enhance the in vivo proliferation of
antigen-stimulated naive CD4 T cells via a CD28-dependent
mechanism that does not involve increased expression of
CD28 ligands,” European Journal of Immunology, vol. 34, no.
4, pp. 1085–1090, 2004.
[26] M. L. Dustin, A. K. Chakraborty, and A. S. Shaw, “Under-
standing the structure and function of the immunological
synapse,” Cold Spring Harbor Perspectives in Biology, vol. 2, no.
10, Article ID a002311, 2010.
[27] B. Alarcon, D. Mestre, and N. Martinez-Martin, “The immu-
nological synapse: a cause or consequence of T-cell receptor
triggering?” Immunology, vol. 133, no. 4, pp. 420–425, 2011.
[28] D. R. Fooksman, S. Vardhana, G. Vasiliver-Shamis et al.,
“Functional anatomy of T cell activation and synapse forma-
tion,”AnnualReviewofImmunology,vol.28,pp.79–105,2010.Clinical and Developmental Immunology 7
[29] A. Grakoui, S. K. Bromley, C. Sumen et al., “The immunologi-
calsynapse:amolecularmachinecontrollingTcellactivation,”
Science, vol. 285, no. 5425, pp. 221–227, 1999.
[30] R. Varma, G. Campi, T. Yokosuka, T. Saito, and M. L. Dustin,
“T Cell receptor-proximal signals are sustained in peripheral
microclusters and terminated in the central supramolecular
activationcluster,”Immunity,vol.25,no.1,pp.117–127,2006.
[31] T. Yokosuka and T. Saito, “Dynamic regulation of T-cell cos-
timulation through TCR-CD28 microclusters,” Immunological
Reviews, vol. 229, no. 1, pp. 27–40, 2009.
[32] I. Tskvitaria-Fuller, A. L. Rozelle, H. L. Yin, and C. W¨ ulﬁng,
“Regulation of sustained actin dynamics by the TCR and cos-
timulation as a mechanism of receptor localization,” Journal of
Immunology, vol. 171, no. 5, pp. 2287–2295, 2003.
[33] S. A. Wetzel, T. W. McKeithan, and D. C. Parker, “Live-cell
dynamics and the role of costimulation in immunological
synapse formation,” Journal of Immunology, vol. 169, no. 11,
pp. 6092–6101, 2002.
[34] C. Wulﬁng, C. Sumen, M. D. Sjaastad, L. C. Wu, M. L. Dustin,
and M. M. Davis, “Costimulation and endogenous MHC
ligands contribute to T cell recognition,” Nature Immunology,
vol. 3, no. 1, pp. 42–47, 2002.
[ 3 5 ]A .R .O .W a t s o na n dW .T .L e e ,“ D i ﬀerences in signaling mol-
ecule organization between naive and memory CD4+ Tl y m -
phocytes,” Journal of Immunology, vol. 173, no. 1, pp. 33–41,
2004.
[36] M.F.Bachmann,A.Gallimore,S.Linkertetal.,“Developmen-
tal regulation of Lck targeting to the CD8 coreceptor controls
signaling in naive and memory T cells,” Journal of Experimen-
tal Medicine, vol. 189, no. 10, pp. 1521–1529, 1999.
[37] K. Flynn and A. M¨ ullbacher, “Memory alloreactive cytotoxic
T cells do not require costimulation for activation in vitro,”
ImmunologyandCellBiology,vol.74,no.5,pp.413–420,1996.
[38] S. K. Kim, K. S. Schluns, and L. Lefranc ¸ois, “Induction
and visualization of mucosal memory CD8 T cells following
systemic virus infection,” Journal of Immunology, vol. 163, no.
8, pp. 4125–4132, 1999.
[39] D. R. Alexander, “The CD45 tyrosine phosphatase: a positive
and negative regulator of immune cell function,” Seminars in
Immunology, vol. 12, no. 4, pp. 349–359, 2000.
[40] E. N. Kersh, S. M. Kaech, T. M. Onami et al., “TCR signal
transductioninantigen-speciﬁcmemoryCD8Tcells,”Journal
of Immunology, vol. 170, no. 11, pp. 5455–5463, 2003.
[41] R. T. Abraham and A. Weiss, “Jurkat T cells and development
of the T-cell receptor signalling paradigm,” Nature Reviews
Immunology, vol. 4, no. 4, pp. 301–308, 2004.
[42] J. E. Smith-Garvin, G. A. Koretzky, and M. S. Jordan, “T cell
activation,” Annual Review of Immunology, vol. 27, pp. 591–
619, 2009.
[43] M. Wang, D. Windgassen, and E. T. Papoutsakis, “Compara-
tive analysis of transcriptional proﬁling of CD3+,C D 4 + and
CD8+ T cells identiﬁes novel immune response players in T-
Cell activation,” BMC Genomics, vol. 9, p. 225, 2008.
[44] M. R. Von Essen, M. Kongsbak, P. Schjerling, K. Olgaard, N.
Ødum, and C. Geisler, “Vitamin D controls T cell antigen
receptor signaling and activation of human T cells,” Nature
Immunology, vol. 11, no. 4, pp. 344–349, 2010.
[45] P. O. Ericsson, P. L. Orchansky, D. A. Carlow, and H. S. Teh,
“Diﬀerential activation of phospholipase C-γ1 and mitogen-
activated protein kinase in naive and antigen-primed CD4 T
cells by the peptide/MHC ligand,” Journal of Immunology, vol.
156, no. 6, pp. 2045–2053, 1996.
[ 4 6 ]S .P i l l a i ,D .D .B i k l e ,M .J .S u ,A .R a t n a m ,a n dJ .A b e ,“ 1 , 2 5 -
Dihydroxyvitamin D3 upregulates the phosphatidylinositol
signaling pathway in human keratinocytes by increasing phos-
pholipaseClevels,”JournalofClinicalInvestigation,vol.96,no.
1, pp. 602–609, 1995.
[47] Z. Xie and D. D. Bikle, “Cloning of the human phospholipase
C-γ1 promoter and identiﬁcation of a DR6-type vitamin D-
responsive element,” Journal of Biological Chemistry, vol. 272,
no. 10, pp. 6573–6577, 1997.
[48] K. Adachi and M. M. Davisa, “T-cell receptor ligation induces
distinct signaling pathways in na¨ ıve vs. antigen-experienced T
cells,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 108, no. 4, pp. 1549–1554, 2011.
[49] C. M. Veldman, M. T. Cantorna, and H. F. DeLuca, “Expres-
sion of 1,25-dihydroxyvitamin D3 receptor in the immune
system,” Archives of Biochemistry and Biophysics, vol. 374, no.
2, pp. 334–338, 2000.
[50] J. M. Curtsinger and M. F. Mescher, “Inﬂammatory cytokines
as a third signal for T cell activation,” Current Opinion in Im-
munology, vol. 22, no. 3, pp. 333–340, 2010.
[51] J. M. Curtsinger, C. S. Schmidt, A. Mondino et al., “Inﬂam-
matory cytokines provide a third signal for activation of naive
CD4+ and CD8+ Tc e l l s , ”Journal of Immunology, vol. 162, no.
6, pp. 3256–3262, 1999.
[52] C. S. Schmidt and M. F. Mescher, “Adjuvant eﬀe c to fI L - 1 2 :
conversion of peptide antigen administration from tolerizing
to immunizing for CD8+ Tc e l l sin vivo,” Journal of Immunol-
ogy, vol. 163, no. 5, pp. 2561–2567, 1999.
[53] J. M. Curtsinger, J. O. Valenzuela, P. Agarwal, D. Lins, and M.
F. Mescher, “Cutting edge: type I IFNs provide a third signal to
CD8 T cells to stimulate clonal expansion and diﬀerentiation,”
Journal of Immunology, vol. 174, no. 8, pp. 4465–4469, 2005.
[54] A. Le Bon, V. Durand, E. Kamphuis et al., “Direct stimulation
of T cells by type I IFN enhances the CD8+ T cell response
during cross-priming,” Journal of Immunology, vol. 176, no. 8,
pp. 4682–4689, 2006.
[55] A. G. Sikora, N. Jaﬀarzad, Y. Hailemichael et al., “IFN-α
enhances peptide vaccine-induced CD8+ Tc e l ln u m b e r s ,e f -
fector function, and antitumor activity,” Journal of Immunol-
ogy, vol. 182, no. 12, pp. 7398–7407, 2009.
[56] Z. Xiao, K. A. Casey, S. C. Jameson, J. M. Curtsinger, and M. F.
Mescher, “Programming for CD8 T cell memory development
requiresIL-120ortypeIIFN,”JournalofImmunology,vol.182,
no. 5, pp. 2786–2794, 2009.
[57] P. Aichele, H. Unsoeld, M. Koschella, O. Schweier, U. Kalinke,
and S. Vucikuja, “Cutting edge: CD8 T cells speciﬁc for lym-
phocytic choriomeningitis virus require type I IFN receptor
for clonal expansion,” Journal of Immunology, vol. 176, no. 8,
pp. 4525–4529, 2006.
[58] K. A. Pape, A. Khoruts, A. Mondino, and M. K. Jenkins,
“Inﬂammatory Cytokines Enhance the In Vivo Clonal Expan-
sion and Diﬀerentiation of Antigen-Activated CD4+ TC e l l s , ”
Journal of Immunology, vol. 159, no. 2, pp. 591–598, 1997.
[59] J. P. Huber and J. David Farrar, “Regulation of eﬀector and
memory T-cell functions by type I interferon,” Immunology,
vol. 132, no. 4, pp. 466–474, 2011.
[60] J. K. Northrop, R. M. Thomas, A. D. Wells, and H. Shen,
“Epigenetic remodeling of the IL-2 and IFN-γ loci in memory
CD8TcellsisinﬂuencedbyCD4Tcells,”JournalofImmunolo-
gy, vol. 177, no. 2, pp. 1062–1069, 2006.
[61] A. Murayama, K. Sakura, M. Nakama et al., “A speciﬁc CpG
site demethylation in the human interleukin 2 gene promoter
is an epigenetic memory,” EMBO Journal,v o l .2 5 ,n o .5 ,p p .
1081–1092, 2006.8 Clinical and Developmental Immunology
[62] R. M. Thomas, L. Gao, and A. D. Wells, “Signals from CD28
induce stable epigenetic modiﬁcation of the IL-2 promoter,”
Journal of Immunology, vol. 174, no. 8, pp. 4639–4646, 2005.
[63] M. S. Kim, T. Kondo, I. Takada et al., “DNA demethylation in
hormone-induced transcriptional derepression,” Nature, vol.
461, no. 7266, pp. 1007–1012, 2009.